The Molecular and Cellular Basis of Neurodegenerative Diseases. Underlying Mechanisms

Table of Contents

1. General Overview 2. Prion Diseases 3. Alzheimer's disease: towards a quantitative biological approach in describing its natural history and underlying mechanisms 4. Neurodegeneration and the ordered assembly of Tau 5. ALS and Other TDP43 Proteinopathies 6. Parkinson's Disease and Other Synucleinopathies 7. Huntington's Disease and Other Polyglutamine Disorders 8. Prion-like propagation in Neurodegenerative Diseases 9. Neurodegenerative Diseases as Protein Folding Disorders 10. Heat shock proteins and protein quality control in Alzheimer's disease 11. Neurodegenerative Diseases and Autophagy 12. Neurodegenerative Diseases and Axonal Transport 13. Mitochondrial Function and Neurodegenerative Diseases 14. Neurodegenerative Diseases and Non-cell autonomous toxicity 15. Neurodegenerative Diseases and RNA-mediated toxicity 16. Neuroinflammation in Age-Related Neurodegenerative Diseases 17. Neurodegenerative Diseases and the Aging Brain

Authors

Michael S. Wolfe Professor of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Michael S. Wolfe is the Mathias P. Mertes Professor of Medicinal Chemistry at the University of Kansas. He received his B.S. in chemistry in 1984 from the Philadelphia College of Pharmacy and Science and Ph.D. in medicinal chemistry in 1990 from the University of Kansas. After postdoctoral stints at the University of Kansas (medicinal chemistry) and the NIH (cell biology), he joined the faculty of the University of Tennessee in Memphis in 1994. In 1999, he joined the faculty at Brigham and Women's Hospital and Harvard Medical School in Boston, becoming Professor of Neurology in 2008. Prof. Wolfe's work has focused on understanding the molecular basis of Alzheimer's disease and related disorders, and identifying effective approaches for pharmacological intervention. Awards for his work include the Sato Memorial International Award in bioorganic and medicinal chemistry from the Pharmaceutical Society of Japan (2003), the MetLife Award for Biomedical Research (2008), a Zenith Fellows Award from the Alzheimer's Association (2008), and the Potamkin Prize from the American Academy of Neurology (2009).